Zynerba Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ZYNE and buy or sell other stocks, ETFs, and their options commission-free!About ZYNE
Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on the research and development of rare and near-rare neuropsychiatric conditions.
CEOArmando Anido, MBA
CEOArmando Anido, MBA
Employees—
Employees—
HeadquartersDevon, Pennsylvania
HeadquartersDevon, Pennsylvania
Founded2007
Founded2007
Employees—
Employees—
ZYNE Key Statistics
Market cap70.12M
Market cap70.12M
Price-Earnings ratio-1.63
Price-Earnings ratio-1.63
Dividend yield—
Dividend yield—
Average volume585.87K
Average volume585.87K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.40
52 Week high$1.40
52 Week low$0.25
52 Week low$0.25
People also own
Based on the portfolios of people who own ZYNE. This list is generated using Robinhood data, and it’s not a recommendation.